An Act to amend the Federal Food, Drug, and Cosmetic Act to authorize human drug application, prescription drug establishment, and prescription drug product fees and for other purposes.
Acronyms (colloquial)
PDUFA, DSA
Nicknames
Dietary Supplement Act of 1992
Enacted by
the 102nd United States Congress
Effective
October 29, 1992
Citations
Public law
102-571
Statutes at Large
106 Stat. 4491
Codification
Acts amended
Federal Food, Drug and Cosmetic Act
Titles amended
21 U.S.C.: Food and Drugs
U.S.C. sections amended
21 U.S.C. ch. 9, subch. VII § 379g et seq.
Legislative history
Introduced in the House as H.R. 6181 by John Dingell (D–MI) on October 6, 1992
Committee consideration by House Energy and Commerce
Passed the House on October 6, 1992 (passed without objection)
Passed the Senate on October 7, 1992 (passed voice vote)
Signed into law by President George H. W. Bush on October 29, 1992
The Prescription Drug User Fee Act (PDUFA) was a law passed by the United States Congress in 1992 which allowed the Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the new drug approval process. The Act provided that the FDA was entitled to collect a substantial application fee from drug manufacturers at the time a New Drug Application (NDA) or Biologics License Application (BLA) was submitted, with those funds designated for use only in Center for Drug Evaluation and Research (CDER) or Center for Biologics Evaluation and Research (CBER) drug approval activities. In order to continue collecting such fees, the FDA is required to meet certain performance benchmarks, primarily related to the speed of certain activities within the NDA review process.
and 25 Related for: Prescription Drug User Fee Act information
most significant provisions of the act: The act reauthorized, for five more years, the PrescriptionDrugUserFeeAct of 1992 (PDUFA). The purpose of this...
Medical Device UserFee and Modernization Act (MDUFA) authorizes the Center for Devices and Radiological Health (CDRH) to collect userfees from medical...
also reauthorizes the PrescriptionDrugUserFeeAct. The PFUDA was first enacted in 1992 to allow the FDA to collect application fees from pharmaceutical...
mission as approving as many drugs it can, regardless of whether the drugs are safe or needed" The PrescriptionDrugUserFeeAct allows the FDA to augment...
product. Under current PrescriptionDrugUserFeeAct targets, the FDA aims to complete and act upon reviews of priority drugs within six months instead...
most drugs as defined in the Food, Drug, and Cosmetic Act. Some biological products are also legally considered drugs, but they are covered by the Center...
Generic DrugUserFee Amendments of 2012 (GDUFA) was signed into law. The GDUFA was designed to build upon the 20-year-old PrescriptionDrugFeeAct and improve...
Most of the Chapter I regulations are based on the Federal Food, Drug, and Cosmetic Act. Notable sections: 11 — electronic records and electronic signature...
Services, to collect drug application and supplement fees, prescriptiondrug establishment fees, and prescriptiondrug product fees to support the FDA process...
The United States commissioner of food and drugs is the head of the Food and Drug Administration (FDA), an agency of the United States Department of Health...
Under the PrescriptionDrugUserFeeAct, the Food and Drug Administration has a limited timespan (known as the PDUFA date) to decide a New Drug Application...
Amendment – requires drug manufacturers to provide proof of the effectiveness and safety of drugs before approval. PrescriptionDrugUserFeeAct – allows the...
Safety Modernization Act (FSMA) was signed into law by President Barack Obama on January 4, 2011. The FSMA has given the Food and Drug Administration (FDA)...
cardiologist who currently serves as the 25th Commissioner of the Food and Drug Administration. He was first nominated to be commissioner in September 2015...
well as orphan drug and breakthrough therapy designations. Approval was granted 3.7 months ahead of the PrescriptionDrugUserFeeAct (PDUFA) date. AbbVie...
filing and granted priority review for tafasitamab, setting a PrescriptionDrugUserFeeAct (PDUFA) goal date of August 30, 2020. On July 31, 2020, Monjuvi...
who advocated successfully for the passage of the landmark Pure Food and DrugAct of 1906 and subsequently worked at the Good Housekeeping Institute laboratories...